BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 31319067)

  • 1. Metformin suppresses cancer cell growth in endometrial carcinoma by inhibiting PD-L1.
    Xue J; Li L; Li N; Li F; Qin X; Li T; Liu M
    Eur J Pharmacol; 2019 Sep; 859():172541. PubMed ID: 31319067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metformin Promotes Antitumor Immunity via Endoplasmic-Reticulum-Associated Degradation of PD-L1.
    Cha JH; Yang WH; Xia W; Wei Y; Chan LC; Lim SO; Li CW; Kim T; Chang SS; Lee HH; Hsu JL; Wang HL; Kuo CW; Chang WC; Hadad S; Purdie CA; McCoy AM; Cai S; Tu Y; Litton JK; Mittendorf EA; Moulder SL; Symmans WF; Thompson AM; Piwnica-Worms H; Chen CH; Khoo KH; Hung MC
    Mol Cell; 2018 Aug; 71(4):606-620.e7. PubMed ID: 30118680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upregulation of programmed death ligand 1 by liver kinase B1 and its implication in programmed death 1 blockade therapy in non-small cell lung cancer.
    Shen X; Zhao Y; Liu G; Zhou HL; Fan J; Zhang L; Li YL; Wang Y; Liang J; Xu ZX
    Life Sci; 2020 Sep; 256():117923. PubMed ID: 32522567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metformin inhibits 17β-estradiol-induced epithelial-to-mesenchymal transition via βKlotho-related ERK1/2 signaling and AMPKα signaling in endometrial adenocarcinoma cells.
    Liu Z; Qi S; Zhao X; Li M; Ding S; Lu J; Zhang H
    Oncotarget; 2016 Apr; 7(16):21315-31. PubMed ID: 26824324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metformin inhibits estrogen-dependent endometrial cancer cell growth by activating the AMPK-FOXO1 signal pathway.
    Zou J; Hong L; Luo C; Li Z; Zhu Y; Huang T; Zhang Y; Yuan H; Hu Y; Wen T; Zhuang W; Cai B; Zhang X; Huang J; Cheng J
    Cancer Sci; 2016 Dec; 107(12):1806-1817. PubMed ID: 27636742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Research of the influence and mechanism about metformin on the proliferation of differentiated endometrial carcinoma cells].
    Wang J; Shi H; Xie Y; Peng Z
    Zhonghua Fu Chan Ke Za Zhi; 2015 Sep; 50(9):685-91. PubMed ID: 26675396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metformin inhibits proliferation and migration of endometrial cancer cells through regulating PI3K/AKT/MDM2 pathway.
    Qiang P; Shao Y; Sun YP; Zhang J; Chen LJ
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1778-1785. PubMed ID: 30840303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination simvastatin and metformin synergistically inhibits endometrial cancer cell growth.
    Kim JS; Turbov J; Rosales R; Thaete LG; Rodriguez GC
    Gynecol Oncol; 2019 Aug; 154(2):432-440. PubMed ID: 31178149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect and regulation of metformin on endometrial carcinoma subline of progestin-resistance].
    Niu YJ; Shi HR; Xie Y
    Zhonghua Fu Chan Ke Za Zhi; 2016 Feb; 51(2):135-40. PubMed ID: 26917483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metformin promotes progesterone receptor expression via inhibition of mammalian target of rapamycin (mTOR) in endometrial cancer cells.
    Xie Y; Wang YL; Yu L; Hu Q; Ji L; Zhang Y; Liao QP
    J Steroid Biochem Mol Biol; 2011 Sep; 126(3-5):113-20. PubMed ID: 21168492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metformin Liposome-Mediated PD-L1 Downregulation for Amplifying the Photodynamic Immunotherapy Efficacy.
    Xiong W; Qi L; Jiang N; Zhao Q; Chen L; Jiang X; Li Y; Zhou Z; Shen J
    ACS Appl Mater Interfaces; 2021 Feb; 13(7):8026-8041. PubMed ID: 33577301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Preliminary investigation of the expression and functions of insulin receptor isoforms in endometrial carcinoma].
    Zhang G; Li XP; Wang JL; Wei LH
    Zhonghua Fu Chan Ke Za Zhi; 2012 Nov; 47(11):839-45. PubMed ID: 23302125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chitosan oligosaccharide regulates AMPK and STAT1 pathways synergistically to mediate PD-L1 expression for cancer chemoimmunotherapy.
    Chen J; Zhou Z; Zheng C; Liu Y; Hao R; Ji X; Xi Q; Shen J; Li Z
    Carbohydr Polym; 2022 Feb; 277():118869. PubMed ID: 34893274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metformin inhibits growth of human non-small cell lung cancer cells via liver kinase B-1-independent activation of adenosine monophosphate-activated protein kinase.
    Guo Q; Liu Z; Jiang L; Liu M; Ma J; Yang C; Han L; Nan K; Liang X
    Mol Med Rep; 2016 Mar; 13(3):2590-6. PubMed ID: 26847819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of metformin on endometrial cancer cell growth in vivo: a preoperative prospective trial.
    Mitsuhashi A; Kiyokawa T; Sato Y; Shozu M
    Cancer; 2014 Oct; 120(19):2986-95. PubMed ID: 24917306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metformin amplifies chemotherapy-induced AMPK activation and antitumoral growth.
    Rocha GZ; Dias MM; Ropelle ER; Osório-Costa F; Rossato FA; Vercesi AE; Saad MJ; Carvalheira JB
    Clin Cancer Res; 2011 Jun; 17(12):3993-4005. PubMed ID: 21543517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metformin and AICAR regulate NANOG expression via the JNK pathway in HepG2 cells independently of AMPK.
    Shen C; Ka SO; Kim SJ; Kim JH; Park BH; Park JH
    Tumour Biol; 2016 Aug; 37(8):11199-208. PubMed ID: 26939902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of immune regulatory molecules B7-H4 and PD-L1 in low and high grade endometrial tumors.
    Bregar A; Deshpande A; Grange C; Zi T; Stall J; Hirsch H; Reeves J; Sathyanarayanan S; Growdon WB; Rueda BR
    Gynecol Oncol; 2017 Jun; 145(3):446-452. PubMed ID: 28347512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual Blockade of Lactate/GPR81 and PD-1/PD-L1 Pathways Enhances the Anti-Tumor Effects of Metformin.
    Chen S; Zhou X; Yang X; Li W; Li S; Hu Z; Ling C; Shi R; Liu J; Chen G; Song N; Jiang X; Sui X; Gao Y
    Biomolecules; 2021 Sep; 11(9):. PubMed ID: 34572586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. γ-Glutamyl cyclotransferase contributes to endometrial carcinoma malignant progression and upregulation of PD-L1 expression during activation of epithelial-mesenchymal transition.
    Xu S; Yang Y; Wang X; Liu X; Jin C; Ma M; Wu S; Li Y
    Int Immunopharmacol; 2020 Apr; 81():106039. PubMed ID: 31757677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.